By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway
Suite B
Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


Company News
Provectus Announces Extension Of Rights Offering 2/13/2017 6:49:59 AM
Provectus Announces Commencement Of Rights Offering To Existing Stockholders And Holders Of Certain Warrants 1/31/2017 8:13:54 AM
Provectus Fires Peter Culpepper as Interim CEO and COO 12/29/2016 6:45:41 AM
Provectus Announces Two Poster Presentations On PV-10 For Liver Tumors 12/22/2016 1:53:59 PM
Provectus Announces Agreement With POETIC (Pediatric Oncology Experimental Therapeutics Investigators Consortium) To Study Potential Of PV-10 For Pediatric Cancer 12/8/2016 12:56:11 PM
Provectus Announces Notification Of NYSE MKT Listing Deficiency 12/1/2016 8:26:47 AM
Provectus Announces Poster Presentation On PV-10 At Society For Immunotherapy Of Cancer 2016 Annual Meeting 11/14/2016 11:48:59 AM
Provectus Reports Third Quarter 2016 Financial Results 11/11/2016 11:34:05 AM
Provectus Will Hold Its 2016 Third Quarter Business Update Conference Call On Monday, November 14, 2016, At 4 PM Eastern Standard Time 10/25/2016 10:50:47 AM
Trading In Provectus Common Stock And Warrants Suspended By NYSE MKT 10/17/2016 1:23:21 PM